Concepedia

Isidore Faiferman

IF

15

Publications

1.8K

Citations

15

H-Index

1966

Active since

Affiliations

New York Blood Center(Current)

Kettering University

Medicines Evaluation Unit

Icahn School of Medicine at Mount Sinai

GlaxoSmithKline (United States)

Isidore Faiferman is an author at New York Blood Center specializing in medicine, allergy, and pathology.

Top concepts

Publications per year

1966–2007

15

Publications

15

A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

Patrick Flood-Page, Cheri A. Swenson, Isidore Faiferman et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 737 citations

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

J B Winfield, Isidore Faiferman, David Koffler · Journal of Clinical Investigation · 1977 · 407 citations · Full text

, , +22

Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects

Allan J. Hamilton, Isidore Faiferman, Paul Stober et al. · Journal of Allergy and Clinical Immunology · 1998 · 137 citations

, , +9

Results of the First U.S. Double-Blind, Placebo-Controlled, Multicenter Clinical Study in Asthma with Pranlukast, a Novel Leukotriene Receptor Antagonist

Jay Grossman, Isidore Faiferman, Jeffrey W. Dubb et al. · Journal of Asthma · 1997 · 81 citations

, , +13

A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma

David I. Bernstein, Jeffrey W. Dubb, Isidore Faiferman et al. · Journal of Allergy and Clinical Immunology · 1996 · 77 citations

, , +6

Rows per page

1–5 of 15